Compare Snap On Incorporated (SNA) vs BIO-TECHNE Corp (TECH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Snap On Incorporated vs BIO-TECHNE Corp — how do they compare? Snap On Incorporated trades at $402.3 (market cap $21.06B), while BIO-TECHNE Corp trades at $71.63 (market cap $11.16B). The key difference: Snap On Incorporated is the larger of the two by market cap, and Snap On Incorporated pays the higher dividend (2.4%). Which is the better fit depends on your goals.
| SNA | TECH | |
|---|---|---|
Market Cap | $21.06B | $11.16B |
Sector | Technology | Health |
52-Week High | $414.97 | $72.12 |
52-Week Low | $317.79 | $43.31 |
Enterprise Value | $20.58B | $11.24B |
Dividend Yield | 2.4% | 0.45% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Snap-on Incorporated (SNA) trades at $406.53, down 1.09% on the day, near the consensus price target of $407.50. The stock shows a bullish technical trend with strong moving average signals and support at $403. Fundamentally, SNA maintains robust profitability with a 19.6% net income margin and 17.83% ROE, though Q1 2026 EPS slightly missed expectations. Recent acquisitions like Diesel Laptops for $100 million highlight strategic growth initiatives.
Outlook remains positive with 65% analyst buy ratings and a dividend yield supported by consistent cash flow. Key risks include margin pressures and muted revenue growth. The upcoming Q2 2026 earnings report on July 23, 2026, will be critical for validating current valuation multiples amid economic uncertainty.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Snap On Incorporated
Snap-on Incorporated is a leading global innovator, manufacturer, and marketer of tools, equipment, diagnostics, repair information, and systems solutions for professional users. Its products are widely used in vehicle service and repair, as well as in other demanding industrial environments. The company is best known for its premium tool brand, often sold through a network of franchised mobile stores, and is a primary supplier to technicians in the transportation industry.
Read more on SNA →About BIO-TECHNE Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →
